ESR1 and breast cancer: For example, an investigator used [ER− PR−] MDA-MB-231 and ER+ MCF7 breast cancer cell lines along with MCF10A control cells in their study for combinatorial epigenetic mechanisms of sulforaphane, genistein, and sodium butyrate in breast cancer inhibition [12].